Arthritis Drugs Remain on Hot Seat
382454
Merck &amp; Co. forced one of its researchers to remove her name from a study linking Vioxx to heart attacks, then criticized the findings before ultimately pulling the arthritis drug from the market last fall, two of the scientist's colleagues say.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
507003
BEIJING, Dec. 23 -- Celebrex, a painkiller prescribed to people with arthritis, is still selling well in Shanghai even though US experts recently found an increased risk of heart attacks and strokes for patients taking high dosages of the drug.
90441
The drug maker says a three-year study of the arthritis pain medication demonstrated a higher risk of heart attack and stroke in patients using the drug.
104715
There are many other treatment options for people with arthritis, and physicians are considering them patient by patient. Washington -- Physicians are pulling out their risk-versus-benefit calculators once
119747
Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say...
33055
From coast to coast, warnings about several popular anti-inflammatory painkillers are triggering  confusion and anxiety.
14652
European drug regulators are conducting a safety review of four arthritis drugs amid reports that they could increase the risk of strokes and heart attacks.
433075
When pharmaceutical giant Merck &amp; Co. abruptly pulled its arthritis pain medication Vioxx from the marketplace on Sept. 30, more than 2 million patients were taking the drug.
116806
WASHINGTON - Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say...
745709
At a research and development meeting for analysts on Nov. 30, Pfizer (PFE ) stayed on message all day long. Despite questions about possible safety issues with arthritis pain medication Celebrex, patent challenges
482024
Vioxx and other pain-relieving drugs have given many people with chronic pain the chance to resume normal lives. But an increase in heart attacks among users of the popular arthritis drug led the manufacturer to pull it from the market and has cast a shadow over similar medications.
214469
Medicines watchdogs are reviewing safety data for an entire class of drugs taken by millions of patients with arthritis and severe pain after the worldwide withdrawal of Merck&#39;s Vioxx last week.
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
483607
This hasn&#39;t been a great year for arthritis sufferers - it hasn&#39;t been a good one for the drug industry or the Food and Drug Administration, either.
306536
TORONTO (CP) - In the wake of last week&#39;s surprise market withdrawal of wonder drug Vioxx, scientists Wednesday questioned the safety of the entire class of arthritis drugs known as Cox-2 inhibitors.
165835
Celebrex continues to sell, while Vioxx got yanked. Courts, doctors, patients, and investors will decide which approach is better.